Processing-Independent Analysis in the Diagnosis of Gastrinomas

REFERENCES

• Meko JB, Norton JA. Management of patients with Zollinger- Ellison syndrome. Annu Rev Med 1995;46:395–411.
   PubMed Web of Science ®Google Scholar
• Bardram L. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy? Gastroenterology 1990;98:1420–6.
   PubMed Web of Science ®Google Scholar
• Zimmer T, Stolzel U, Bader M, Fett U, Foss HD, Riecken EO, et al. A duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations. N Engl J Med 1995;333:634–6.
   PubMed Web of Science ®Google Scholar
• Jais P, Mignon M. Normal serum gastrin concentration in gastrinoma. Lancet 1995;346:1421–2.
   PubMedGoogle Scholar
• Pauwels S, Desmond H, Dimaline R, Dockray GJ. Identification of progastrin in gastrinomas, antrum and duodenum by a novel radioimmunoassay. J Clin Invest 1986;77:376–81.
   PubMed Web of Science ®Google Scholar
• Bardram L. Progastrin in pancreas and the Zollinger-Ellison syndrome. Scand J Gastroenterol 1990;25:1185–95.
   PubMed Web of Science ®Google Scholar
• Kothary PC, Mahoney WC, Vinik AI. Identification of gastrin molecular variants in gastrinoma syndrome. Regul Pept 1987; 17:71–84.
   Google Scholar
• Huebner VD, Jiang R, Lee TD, Legesse K, Walsh JH, Shively JE, et al. Purification and structural characterization of progastrin-derived peptides from a human gastrinoma. J Biol Chem 1991;266:12223–7.
   PubMedGoogle Scholar
• Rehfeld JF, Solinge WW van. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994;63:295–347.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Bardram L, Hilsted L. Gastrin in bronchial carcinomas: Constant expression but variable processing of progastrin. Cancer Res 1989;49:2840–3.
   Google Scholar
• Wolfsen AR, Odell WD. ProACTH: use for early detection of lung cancer. Am J Med 1979;66:765–71.
   PubMed Web of Science ®Google Scholar
• Jensen S, Borch K, Hilsted L, Rehfeld JF. Progastrin processing in hypersecretory G-cells in humans. Gastroenterology 1989;96:1063–70.
   PubMed Web of Science ®Google Scholar
• Ciccotosto GD, Mcleish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109:1142–53.
   PubMed Web of Science ®Google Scholar
• Turner RC, Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression test for insulinomas. Diabetologia 1977;13:571–7.
   PubMedGoogle Scholar
• Aoyagi K, Miyake Y, Urakami K, Kahsiwakuma T, Hasegawa A, Kodama T, et al. Enzyme immunoassay of immunoreactive progastrin-releasing peptide(31–98) as tumor marker for smallcell lung carcinoma: development and evaluation. Clin Chem 1995;41:537–43.
   PubMed Web of Science ®Google Scholar
• Bardram L, Rehfeld JF. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products. Anal Biochem 1988;175:537–43.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Bardram L. Processing-independent analysis (PIA)—a new diagnostic tool. Scand J Clin Lab Invest 1991; 51 Suppl 204:9–16.
   Google Scholar
• Paloheimo LI, Rehfeld JF. Quantitation of procholecystokinin and its products in plasma by processing-independent analysis. Clin Chim Acta 1995;238:21–33.
   PubMed Web of Science ®Google Scholar
• Bardram L, Rehfeld JF. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin. Scand J Clin Lab Invest 1989;49:173–82.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972;30:221–32.
   PubMed Web of Science ®Google Scholar
• Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104:1356–70.
   Google Scholar
• Lazzaroni M, Sangaletti O, Bianchi-Porro G. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients. Hepato- gastroenterology 1992;39:366–70.
   Google Scholar
• Creutzfeldt W, Lamberts R. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. Digestion 1992;51 Suppl 1:76–81.
   PubMed Web of Science ®Google Scholar
• Tari A, Hamada M, Kamiyasu T, Fukino Y, Sumii M, Sumii K, et al. Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues. Dig Dis Sci 1996;41:1150–6.
   PubMedGoogle Scholar
• Hurwitz A, Sztern MI, Looney GA, Pinson DM, Bauer KD, Kimler BF. Effects of omeprazole on cell kinetics of carcinogen- induced colon tumors in rats. Cell Prolif 1995;28:525–31.
   PubMedGoogle Scholar
• Solinge WW van, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993;104:1099–107.
   PubMedGoogle Scholar
• Kochmann ML, DelValle J, Dickinson Cj, Boland CR. Posttranslational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun 1992;189:1165–9.
   PubMedGoogle Scholar
• Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993;34:90–5.
   Google Scholar
• Singh P, Xu Z, Dai B, Rajaraman S, Rubin N, Dhruva B. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am J Physiol 1994;266:G459–68.
   PubMed Web of Science ®Google Scholar
• Imdahl A, Mantamadiotis T, Eggstein S, Farthmann EH, Baldwin GS. Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas. J Cancer Res Clin Oncol 1995;121:661–6.
   Google Scholar